Literature DB >> 22351149

[Sleep-disordered breathing and cardiac arrhythmias].

T Bitter1, B Körber, D Horstkotte, O Oldenburg.   

Abstract

Sleep-disordered breathing (SDB) is an important comorbidity in patients with cardiac arrhythmias. Previous studies confirmed associations between supraventricular and ventricular arrhythmias and SDB. In heart failure patients, SDB was also found independently associated with a shorter event-free survival to the occurrence of malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapy. In obstructive sleep apnea, repetitive hypoxemia, mechanical stress (wall tension), arousals from sleep, and activation of the sympathetic nervous system promote cardiac arrhythmias. Pathophysiological concepts for the link between Cheyne-Stokes respiration and malignant arrhythmias are not fully understood and require further research. In addition, large-scale, randomized, controlled trials are awaited to prove whether adequate treatment of SDB is associated with a risk reduction for the occurrence of arrhythmias, in general, and malignant ventricular arrhythmias, in particular, in these patients.

Entities:  

Mesh:

Year:  2012        PMID: 22351149     DOI: 10.1007/s00399-011-0164-8

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  55 in total

1.  Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure.

Authors:  S Javaheri
Journal:  Circulation       Date:  2000-02-01       Impact factor: 29.690

2.  Continuous positive airway pressure for central sleep apnea and heart failure.

Authors:  T Douglas Bradley; Alexander G Logan; R John Kimoff; Frédéric Sériès; Debra Morrison; Kathleen Ferguson; Israel Belenkie; Michael Pfeifer; John Fleetham; Patrick Hanly; Mark Smilovitch; George Tomlinson; John S Floras
Journal:  N Engl J Med       Date:  2005-11-10       Impact factor: 91.245

3.  Oscillations in peripheral arterial tone in congestive heart failure patients: a new marker for Cheyne-Stokes breathing.

Authors:  Dov Freimark; Yehuda Adler; Jacob Sheffy; Doris Schechter; Ehud Schwammenthal; Itay Wiser; Michael Motro; Peretz Lavie
Journal:  Cardiology       Date:  2002       Impact factor: 1.869

4.  Interactions of magnesium and potassium in the pathogenesis of cardiovascular disease.

Authors:  J P Sheehan; M S Seelig
Journal:  Magnesium       Date:  1984

5.  Sleep apnoea induces cardiac electrical instability assessed by T-wave alternans in patients with congestive heart failure.

Authors:  Nobuhiro Takasugi; Kazuhiko Nishigaki; Tomoki Kubota; Kunihiko Tsuchiya; Kenji Natsuyama; Mieko Takasugi; Takahide Nawa; Shinsuke Ojio; Takuma Aoyama; Masanori Kawasaki; Genzou Takemura; Shinya Minatoguchi
Journal:  Eur J Heart Fail       Date:  2009-11       Impact factor: 15.534

6.  Pulmonary capillary wedge pressure and pulmonary arterial pressure in heart failure patients with sleep-disordered breathing.

Authors:  Olaf Oldenburg; Thomas Bitter; Marcus Wiemer; Christoph Langer; Dieter Horstkotte; Cornelia Piper
Journal:  Sleep Med       Date:  2009-01-08       Impact factor: 3.492

7.  Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Susan M Harding
Journal:  Chest       Date:  2004-01       Impact factor: 9.410

Review 8.  Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link.

Authors:  L Lavie; P Lavie
Journal:  Eur Respir J       Date:  2009-06       Impact factor: 16.671

Review 9.  Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.

Authors:  K T Weber; C G Brilla
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

10.  Timing of nocturnal ventricular ectopy in heart failure patients with sleep apnea.

Authors:  Clodagh M Ryan; Stephen Juvet; Richard Leung; T Douglas Bradley
Journal:  Chest       Date:  2008-02-08       Impact factor: 9.410

View more
  1 in total

1.  Adiponectin protects rat myocardium against chronic intermittent hypoxia-induced injury via inhibition of endoplasmic reticulum stress.

Authors:  Wenxiao Ding; Xiaofeng Zhang; Hanpeng Huang; Ning Ding; Shijiang Zhang; Sean Z Hutchinson; Xilong Zhang
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.